These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3577103)

  • 1. [Protective action of virosomes containing influenza virus antigens administered intranasally].
    Andzhaparidze OG; Torchilin VP; Mazhul' LA; Burkhanov SA; Ageeva ON
    Vopr Virusol; 1987; 32(1):112-4. PubMed ID: 3577103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
    Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
    Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The potentials for immunization against influenza using liposome-incorporated viral surface antigens].
    Burducea O; Marcheş F; Duţu C; Grancea C; Nicolau A; Păun C
    Virologie; 1989; 40(2):97-106. PubMed ID: 2781727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunomodulating action of the surface antigens of the influenza A virus in experimental staphylococcal infection].
    Lavrov VF; Orlova NG; Ratgauz GL; Khodakova LP; Mazhul' LA; Kirilicheva GB; Solov'eva MS; Ageeva LA; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):53-6. PubMed ID: 1887712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein.
    Guo L; Zheng M; Ding Y; Li D; Yang Z; Wang H; Chen Q; Sui Z; Fang F; Chen Z
    Arch Virol; 2010 Nov; 155(11):1765-75. PubMed ID: 20652335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different functions of subsets of effector T cells in murine influenza virus infection.
    Leung KN; Ada GL
    Cell Immunol; 1982 Mar; 67(2):312-24. PubMed ID: 6979396
    [No Abstract]   [Full Text] [Related]  

  • 7. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
    Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
    Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization against respiratory viruses in mice.
    Nedrud J; Sigmund N; Brunschwig E; Lamm M
    Adv Exp Med Biol; 1995; 371B():1595-8. PubMed ID: 7502863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
    Nagieva FG; Krasnova NI; Nikulina VG; Andzhaparidze OG
    Vopr Virusol; 1991; 36(3):197-200. PubMed ID: 1891875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccinating effect of conjugates of influenza virus surface antigens with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1984; 277(3):752-5. PubMed ID: 6489120
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
    Cryz SJ; Glück R
    Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased effectiveness of influenza prevention vaccination by using levamisole].
    Pavlishin VV; Savtsova ZD; Giulling EV
    Vopr Virusol; 1984; 29(2):248-50. PubMed ID: 6730442
    [No Abstract]   [Full Text] [Related]  

  • 17. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F; Mucha V; Slováková R; Varecková E
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization with a complex preparation: a new method of influenza prevention. The basis for using a complex preparation for preventing influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV; Shapiro NI; Aksenov OA
    Vopr Virusol; 1982; 27(2):142-6. PubMed ID: 6178215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.